Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major

InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly... see more

Add To Watchlist

Recent & Breaking News (NDAQ:INNV)

Innovus Pharma Signs Exclusive Marketing and Distribution Agreement with Oz Biogenics to Market and Distribute Zestra(R) EjectDelay(R) Sensum+(R) Vesele(R) and Zestra Glide(R) in Myanmar and Vietnam

Accesswire April 13, 2015

Innovus Pharma Signs Exclusive License and Distribution Agreement with BroadMed for Sensum+(R) in Lebanon

Accesswire April 8, 2015

Innovus Pharmaceuticals 2014 Revenues Increase to over $1Million in Its First Full Year of Commercial Operations

Accesswire April 1, 2015

Innovus Pharma Signs Exclusive License and Distribution Agreement with Tabuk Pharmaceuticals for EjectDelay(R), Sensum+(R) and Vesele(R) in Saudi Arabia, the Gulf Countries, North Africa and the Middle East

Accesswire March 23, 2015

Innovus Pharmaceuticals to Sponsor the Living Menopause Positively Event by Oakdale Obstetrics & Gynecology on March 7, 2015 with its Zestra(R) Product

Accesswire February 27, 2015

Innovus Pharmaceuticals Announces the Official Launch of Zestra(R) and Zestra Glide(R) in Morocco by its Partner Sothema Labs with an Initial Order Approximately 200,000 Doses

Accesswire February 16, 2015

Innovus Pharma Enters $1 Billion Worldwide Nasal Steroid Market with the Acquisition of FlutiCare(TM) (Fluticasone Propionate Nasal) Over The Counter ("OTC") Rights from Novalere

Accesswire February 5, 2015

Innovus Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference in New York

Accesswire February 3, 2015

Innovus Pharmaceuticals to Present at OneMedForum in San Francisco

Accesswire January 6, 2015

Innovus Pharma Management Discusses the Company's Revenue Stream and Growth Strategy with TheStockRadio.com

Accesswire December 18, 2014

Innovus Pharma Expands Agreement with Tramorgan Limited to Commercialize Vesele(R) in the United Kingdom

Accesswire December 11, 2014

Innovus Pharmaceuticals to Present at LD Micro Conference in Los Angeles on December 2, 2014

Accesswire November 26, 2014

Innovus Pharmaceuticals Announces a 77% Achievement of Increase in Arousal from a 246 Use Survey Study in British Women that Used Zestra(R)

Accesswire November 25, 2014

Innovus Pharmaceuticals Provides Third Quarter 2014 Financial Results With Commercial and Corporate Update

Accesswire November 14, 2014

Innovus Pharmaceuticals Announces Its Revenue Guidance

Accesswire November 5, 2014

Innovus Pharma CEO, Dr. Bassam Damaj, Featured on Wide World of Stocks Television

Accesswire November 3, 2014

Innovus Announces the Acquisition of Vesele(R), A Safer Proprietary Oral Formualtion to Maximize Nitric Oxide's Beneficial Effects on Sexual Function and Brain Health

Accesswire October 28, 2014

Innovus Pharmaceuticals Receives Approval for the Expanded Label Indication for its Zestra(R) Product in Canada for the Temporary Increase of Desire/Arousal in Women with Female Sexual Interest/Arousal Disorder

Accesswire October 24, 2014

Innovus Pharma Announces Podium Presentation at the World Meeting of Sexual Medicine, Discussing the Clinical Efficacy of Zestra(R) in Cancer Patients

GlobeNewswire October 2, 2014

SeeThruEquity Initiates Research Coverage on Innovus Pharmaceuticals, Inc. with a Target Price of $1.34

Accesswire September 29, 2014